Kenneth H Shain Selected Research

Carcinoma (Carcinomatosis)

10/2022

Replicative Instability Drives Cancer Progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kenneth H Shain Research Topics

Disease

39	Multiple Myeloma 04/2024 - 11/2003
16	Neoplasms (Cancer) 04/2024 - 03/2002
5	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 01/2017
4	Lymphoma (Lymphomas) 01/2022 - 01/2018
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2021 - 01/2017
3	Fanconi Anemia (Fanconi's Anemia) 11/2011 - 11/2003
2	Disease Progression 12/2023 - 01/2018
2	Cardiotoxicity 01/2023 - 01/2018
2	Heart Failure 01/2023 - 01/2023
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2024
1	Chromothripsis 01/2024
1	Ventricular Tachycardia 01/2023
1	Atrial Fibrillation 01/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Cardiomyopathies (Cardiomyopathy) 01/2023
1	Cytopenia 12/2022
1	Infections 12/2022
1	Neoplasm Metastasis (Metastasis) 10/2022
1	Carcinoma (Carcinomatosis) 10/2022
1	Progressive Multifocal Leukoencephalopathy 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Leukoencephalopathies 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Osteolysis 01/2021
1	Hypoxia (Hypoxemia) 01/2019
1	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2019
1	Mucositis 01/2019
1	Residual Neoplasm 04/2016
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2016
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2016
1	Renal Insufficiency (Renal Failure) 09/2013

Drug/Important Bio-Agent (IBA)

11	Lenalidomide (CC 5013)FDA Link 04/2024 - 09/2013
9	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 01/2014
8	Bortezomib (Velcade)FDA Link 04/2024 - 12/2009
6	daratumumabIBA 04/2024 - 01/2020
6	Proteasome InhibitorsIBA 01/2023 - 10/2015
6	Melphalan (Alkeran)FDA LinkGeneric 01/2021 - 11/2003
5	Proteins (Proteins, Gene)FDA Link 10/2023 - 03/2002
4	ibrutinibIBA 01/2021 - 01/2017
3	idecabtagene vicleucelIBA 09/2023 - 12/2022
2	Adenosine Monophosphate (AMP)IBA 04/2024 - 01/2024
2	RNA (Ribonucleic Acid)IBA 12/2023 - 05/2021
2	Chimeric Antigen ReceptorsIBA 09/2023 - 01/2023
2	carfilzomibIBA 01/2023 - 11/2016
2	Immunoglobulins (Immunoglobulin)IBA 01/2022 - 05/2021
2	Histone Deacetylase InhibitorsIBA 12/2021 - 10/2021
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2021 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2009
2	ONX 0912IBA 01/2019 - 01/2019
2	venetoclaxIBA 01/2019 - 01/2017
2	Alkylating AgentsIBA 01/2019 - 12/2009
2	Immunomodulating AgentsIBA 01/2018 - 10/2015
2	selinexorIBA 11/2016 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 10/2015
2	liposomal doxorubicin (Doxil)FDA Link 01/2016 - 01/2014
2	1-dodecylpyridoxal (PLD)IBA 01/2016 - 01/2014
1	Caseins (Casein)FDA Link 12/2023
1	SR-3029IBA 12/2023
1	SurvivinIBA 11/2023
1	VaccinesIBA 11/2023
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023
1	B-Cell Maturation AntigenIBA 01/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022
1	THZ531IBA 01/2022
1	Tumor Biomarkers (Tumor Markers)IBA 01/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2022
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2022
1	Monoclonal AntibodiesIBA 01/2022
1	IgKIBA 01/2022
1	Histones (Histone)IBA 12/2021
1	LCL161IBA 10/2021
1	PanobinostatIBA 10/2021
1	Inhibitor of Apoptosis ProteinsIBA 10/2021
1	Protein Disulfide-IsomerasesIBA 05/2021
1	CytokinesIBA 05/2021
1	Matrix Metalloproteinase 13IBA 01/2021
1	ProdrugsIBA 01/2019
1	azomycinIBA 01/2019
1	TH 302IBA 01/2019
1	6-bromo-2-naphthyl sulfate (BNS)IBA 01/2019
1	isophosphamide mustard (IPAM)IBA 01/2019
1	Oncogene Proteins (Oncogene Protein)IBA 12/2018
1	Phosphotransferases (Kinase)IBA 12/2018
1	ricolinostatIBA 01/2017
1	Exportin 1 ProteinIBA 01/2016
1	Topoisomerase II InhibitorsIBA 01/2016
1	Thalidomide (Thalomid)FDA Link 10/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2015
1	Vincristine (Oncovin)FDA LinkGeneric 10/2015
1	Etoposide (VP 16)FDA LinkGeneric 10/2015

Therapy/Procedure

23	Therapeutics 04/2024 - 12/2009
4	Stem Cell Transplantation 10/2023 - 01/2020
2	Drug Therapy (Chemotherapy) 01/2017 - 10/2015
1	Transplantation 10/2023
1	Hematopoietic Stem Cell Mobilization 01/2023
1	Aftercare (After-Treatment) 01/2021
1	Transcutaneous Electric Nerve Stimulation (TENS) 01/2021
1	Immunomodulation 01/2018